Invention Grant
- Patent Title: Programming of cells for tolerogenic therapies
- Patent Title (中): 用于耐受性治疗的细胞编程
-
Application No.: US13386950Application Date: 2010-08-02
-
Publication No.: US08728456B2Publication Date: 2014-05-20
- Inventor: Roger Warren Sands , Eduardo Alexandra Barros e Silva , Toshihisa Kawai , David J. Mooney
- Applicant: Roger Warren Sands , Eduardo Alexandra Barros e Silva , Toshihisa Kawai , David J. Mooney
- Applicant Address: US MA Cambridge US MA Cambridge
- Assignee: President and Fellows of Harvard College,Forsyth Dental Infirmary for Children
- Current Assignee: President and Fellows of Harvard College,Forsyth Dental Infirmary for Children
- Current Assignee Address: US MA Cambridge US MA Cambridge
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ingrid A. Beattie
- International Application: PCT/US2010/044117 WO 20100802
- International Announcement: WO2011/014871 WO 20110203
- Main IPC: A61K39/35
- IPC: A61K39/35 ; A61K39/00 ; A61K38/20 ; A61K38/19 ; A61P37/04 ; A61P37/06 ; A61P3/10 ; A61P29/00 ; A61P37/08

Abstract:
Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
Public/Granted literature
- US20120121539A1 Programming Of Cells for Tolerogenic Therapies Public/Granted day:2012-05-17
Information query